This systematic review evaluated forty-two studies published between 2024 and 2026 across eleven databases using PRISMA 2020 guidelines and AI-specific quality frameworks and demonstrated high organ segmentation accuracy with Dice coefficients exceeding 0.90, whereas performance declined for infiltrative tumours, and external validation was present in only one-third of studies.
Abstract
Medical artificial intelligence relies heavily on imaging for lesion detection and anatomical quantification, providing essential support for cancer diagnosis and treatment planning (General Background). While foundation models are rapidly transforming radiological workflows, traditional evaluations focus predominantly on technical segmentation metrics rather than clinical utility (Specific Background). Existing literature lacks a comprehensive synthesis combining model taxonomies, multi-task assessments beyond segmentation, and standardized clinical readiness appraisals (Knowledge Gap). This systematic review evaluated forty-two studies published between 2024 and 2026 across eleven databases using PRISMA 2020 guidelines and AI-specific quality frameworks (Aims). Results demonstrated high organ segmentation accuracy with Dice coefficients exceeding 0.90, whereas performance declined for infiltrative tumours, and external validation was present in only one-third of studies (Results). We propose an eight-level clinical-readiness scale and research roadmap to transition medical AI from technical benchmarks to deployment (Novelty). Standardized validation protocols are critical for advancing safe decision support (Implications).
Key Findings Highlights
Current medical foundation models achieve high technical precision in organ segmentation but show reduced performance in low-contrast and post-treatment lesions.
Less than one-third of evaluated studies report external validation, and no interventional prospective trials currently exist.
Transitioning AI to routine oncology care requires establishing standardized clinical endpoints, fairness reporting, and multi-institutional data frameworks.
Keywords: Foundation Models, Medical Imaging, Tumour Quantification, Clinical Decision Support, Systematic Review
Background: Artificial intelligence (AI) is increasingly being incorporated into radiology, not only for image interpretation but also for scheduling, examination protocoling, image acquisition, reconstruction, worklist prioritisation, quantitative analysis, reporting, communication, and follow-up. The clinical value o...
Neelam Rao Bharti, Deeksha Jaiswal, Nidhi Goswami et al.· Genetics and Molecular Resea...· 0 citations
An engineering-oriented deployment framework is proposed, integrating modality-driven model selection, structured preprocessing pipelines, multi-level clinical validation, computational feasibility assessment, and explainability, together with a clinical deployment readiness model spanning validation maturity, data div...
Enoch Jacob Dodo, Amos Takai Yayock, Gregory Onwodi et al.· Journal of Science Research...· 0 citations
Purpose Deep Learning (DL) has transformed cardiac image segmentation, yet its application to congenital heart disease (CHD) remains underexplored, with no prior systematic review in this emerging domain. This review evaluates current DL approaches for CHD CT segmentation, identifies best performing model architectures...
This study provides a clear and actionable framework to bridge the gap between DL‐based segmentation research and clinical deployment, and proposes a roadmap for future research focusing on lightweight architectures, edge–cloud integration, federated learning and explainable AI (XAI).
Muhammad Sufyan, Jun Qian, Jianqiang Li et al.· Expert systems· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.